Centessa Pharmaceuticals plc
(NASDAQ: CNTA)
|
8:00 PM UTC, 06/20/25 | |||
---|---|---|---|---|
Last: $12.43 | Change: -0.25 | %Change: -1.97% | Volume: 1,612,616 |
05:48 PM EDT, 05/20/2025 (MT Newswires) -- Saurabh Saha, Director, Chief Executive Officer, on May 20, 2025, sold 55,000 shares in Centessa Pharmaceuticals (CNTA) for $699,111. Following the Form 4 filing with the SEC, Saha has control over a total of 259,017 common shares of the company, with 221,017 shares held directly and 38,000 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1847903/000184790325000076/xslF345X05/wk-form4_1747777437.xml
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.